A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OS / osteosarcoma

[Related PubMed/MEDLINE]
Total Number of Papers: 1923
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OS  (>> Co-occurring Abbreviation)
Long Form:   osteosarcoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma. ---
2020 Acquisition of stem associated-features on metastatic osteosarcoma cells and their functional effects on mesenchymal stem cells. MSCs
2020 Biology and pathogenesis of human osteosarcoma. ---
2020 Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells. CGA
2020 Cold atmospheric plasma inhibits the growth of osteosarcoma cells by inducing apoptosis, independent of the device used. CAP
2020 Cold Plasma-Treated Ringer's Saline: A Weapon to Target Osteosarcoma. PAR
2020 Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities. ---
2020 Dioscin inhibits the growth of human osteosarcoma by inducing G2/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo. GSDME, PCD
2020 Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p. IGF1R, lncSNHG12
10  2020 Expression of the double-stranded RNA-dependent kinase PKR influences osteosarcoma attachment independent growth, migration, and invasion. DN, PKR
11  2020 Functional variant of IL33 is associated with survival of osteosarcoma patients. ---
12  2020 G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway. Chi3L1, MAPKs
13  2020 Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP. YAP
14  2020 Growth hormone receptor promotes osteosarcoma cell growth and metastases. GHR
15  2020 HSP90 regulates osteosarcoma cell apoptosis by targeting the p53/TCF-1-mediated transcriptional network. Hsp90
16  2020 Identification of osteosarcoma driver genes using a network method. ---
17  2020 Interstitial serum albumin empowers osteosarcoma cells with FAIM2 transcription to obtain viability via dedifferentiation. FAIM2
18  2020 Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway. ---
19  2020 LINC00324 accelerates the proliferation and migration of osteosarcoma through regulating WDR66. lncRNA, WDR66
20  2020 LINC00657 activates PD-L1 to promote osteosarcoma metastasis via miR-106a. PD-L1, RT-qPCR
21  2020 LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway. CRNDE, lncRNAs
22  2020 LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p. DANCR, miR-216a-5p, qRT-PCR
23  2020 LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1. HCC, LncRNAs, RCC
24  2020 LncRNA PCAT6 promotes tumor progression in osteosarcoma via activation of TGF-beta pathway by sponging miR-185-5p. lncRNAs
25  2020 LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-Like polarization of tumor-associated macrophages of CPEB4. ceRNA, CPEB4, lncRNAs, TAMs
26  2020 LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity. lnc, ZEBs
27  2020 LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis. lncRNAs
28  2020 Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458. lncRNA
29  2020 Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1. ---
30  2020 MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2. NOTCH2
31  2020 MicroRNA-150 functions as a tumor suppressor and sensitizes osteosarcoma to doxorubicin-induced apoptosis by targeting RUNX2. miR-150, miRNAs
32  2020 miR-139-mediated NOTCH1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol. ---
33  2020 Multifunctional bone cement for synergistic magnetic hyperthermia ablation and chemotherapy of osteosarcoma. FDA, MH
34  2020 Nanomedicine in osteosarcoma therapy: micelleplexes for delivery of nucleic acids and drugs for osteosarcoma-targeted therapy. ---
35  2020 Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma. ALP, ROC
36  2020 Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B. OSHIGH, SIC
37  2020 Outcomes for pediatric patients with osteosarcoma treated with palliative radiotherapy. EQD2, RT
38  2020 Paeonol antagonizes oncogenesis of osteosarcoma by inhibiting the function of TLR4/MAPK/NF-kappaB pathway. Pae
39  2020 PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma. NHEJ
40  2020 Positive feedback loop SP1/MIR17HG/miR-130a-3p promotes osteosarcoma proliferation and cisplatin resistance. lncRNAs
41  2020 Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. lncRNAs, miRNAs
42  2020 Reduction-responsive polypeptide nanomedicines significantly inhibit progression of orthotopic osteosarcoma. DOX
43  2020 Signatures of circulating microRNA in four sarcoma subtypes. ES, GIST, ROC AUC, SS
44  2020 The microRNA‑708‑5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma. DEmiRNAs, EMT, MAP3K3, SEMA4C, ZEB1
45  2019 A comparison of risk factors for metastasis at diagnosis in humans and dogs with osteosarcoma. ---
46  2019 A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma. AUC, miRNAs, ROC
47  2019 A global transcriptomic pipeline decoding core network of genes involved in stages leading to acquisition of drug-resistance to cisplatin in osteosarcoma cells. ---
48  2019 A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma. hTEBOs, rhBMP-7
49  2019 A newly synthesized oleanolic acid derivative inhibits the growth of osteosarcoma cells in vitro and in vivo by decreasing c-MYC-dependent glycolysis. CDDO-NFM
50  2019 A Novel lncRNA MYOSLID/miR-1286/RAB13 Axis Plays a Critical Role in Osteosarcoma Progression. lncRNA, RIP
51  2019 Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo. CXCL6, EMT
52  2019 Activation of dynamin-related protein 1 - dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone. Bax, CPT, Drp1
53  2019 ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-kappaB Pathway. ACTN4, HE
54  2019 Adjuvant Biophysical Therapies in Osteosarcoma. HIFU, HT, LIPUS, SDT, PDT
55  2019 Advanced development of ErbB family-targeted therapies in osteosarcoma treatment. ---
56  2019 alpha,gamma-Diketocarboxylic Acids and Their Esters Act as Carbonic Anhydrase IX and XII Selective Inhibitors. CA
57  2019 Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance. ceRNA, circRNA, GO, KEGG, lncRNA, miRNA, ncRNAs, RIP
58  2019 Angiogenesis Process in Osteosarcoma: An Updated Perspective of Pathophysiology and Therapeutics. ---
59  2019 Angiopoietin-like protein 2 is an important facilitator of tumor proliferation, metastasis, angiogenesis and glycolysis in osteosarcoma. Angptl2
60  2019 Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma. AR, FASN
61  2019 Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway. mTOR, P. amurense, Phe, PI3K
62  2019 Anticancer Potential of Oleuropein, the Polyphenol of Olive Oil, With 2-Methoxyestradiol, Separately or in Combination, in Human Osteosarcoma Cells. 2-ME
63  2019 Antimetastatic effects of calycosin on osteosarcoma and the underlying mechanism. CC, ECT2, IkappaBalpha, MMP2, PCNA
64  2019 Apiosporamide, A 4-hydroxy-2-pyridone Alkaloid, Induces Apoptosis Via PI3K/Akt Signaling Pathway In Osteosarcoma Cells. ---
65  2019 Association between PTEN and clinical-pathological features of osteosarcoma. CBM, CIs, CNKI, OR, PTEN
66  2019 ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma. ATF4, BTZ, FISH, OS/BTZ
67  2019 ATF6alpha Activation Enhances Survival against Chemotherapy and Serves as a Prognostic Indicator in Osteosarcoma. ER, PDI
68  2019 Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A. IL-6, RA
69  2019 Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional Osteosarcoma. OB
70  2019 Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma. ---
71  2019 Baicalin inhibits growth and induces apoptosis of human osteosarcoma cells by suppressing the AKT pathway. ---
72  2019 Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo. CCK-8, PD-L1, RT-qPCR
73  2019 Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations. EW, PDX
74  2019 Bone transport using the Ilizarov method for osteosarcoma patients with tumor resection and neoadjuvant chemotherapy. EFI
75  2019 BTF3 Silencing Inhibits the Proliferation of Osteosarcoma Cells. BTF3, LV-BTF3-shRNA, MTT
76  2019 C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling. ---
77  2019 Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2. WES
78  2019 Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2. WES
79  2019 Carboxypeptidase E-DeltaN promotes migration, invasiveness, and epithelial-mesenchymal transition of human osteosarcoma cells via the Wnt-beta-catenin pathway. CPE, EMT, siRNA
80  2019 CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition. CDKN2B-AS1, EMT, lncRNAs
81  2019 Characterization of five newly derived canine osteosarcoma cell lines. ---
82  2019 Chinese Herbal Medicine for Osteosarcoma in the Mouse: A Systematic Review and Meta-Analysis. CBM, CHM, Cl, CNKI, MD
83  2019 CircSAMD4A accelerates cell proliferation of osteosarcoma by sponging miR-1244 and regulating MDM2 mRNA expression. circRNAs
84  2019 Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. circRNAs, FISH, RIP
85  2019 Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma. CCK-8, ceRNA, circRNA, qRT-RCR
86  2019 Circ_0001658 promotes the proliferation and metastasis of osteosarcoma cells via regulating miR-382-5p/YB-1 axis. circRNA, miRNA, YB-1
87  2019 CLDN10 promotes a malignant phenotype of osteosarcoma cells via JAK1/Stat1 signaling. CCK-8, CLDNs, JAK1, RNAi, STAT1, TJ
88  2019 Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells. Bcl-2, CC, LD, miR-223, PARP
89  2019 Clinical importance of S100A9 in osteosarcoma development and as a diagnostic marker and therapeutic target. qRT-PCR
90  2019 Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus. MED12
91  2019 Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival. GEO, LASSO, WGCNA
92  2019 Concurrent Osteosarcoma Theranostic Strategy Using Contrast-Enhanced Ultrasound and Drug-Loaded Bubbles. US
93  2019 cPLA2a correlates with metastasis and poor prognosis of osteosarcoma by facilitating epithelial-mesenchymal transition. cPLA2, EMT
94  2019 Craniomaxillofacial osteosarcoma - The role of surgical margins. CMF
95  2019 CRIF1-CDK2 Interface Inhibitors: An Unprecedented Strategy for Modulation of Cell Radiosensitivity. BMSC, CDKs, CRIF1, IR
96  2019 Cross-Species Gene Expression Analysis Reveals Gene Modules Implicated in Human Osteosarcoma. CD86, PPI, WGCNA
97  2019 Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma. DLG2
98  2019 Crosstalk between Hh and Wnt signaling promotes osteosarcoma progression. ---
99  2019 CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis. COP9
100  2019 Curcumin inhibits the proliferation and invasion of MG-63 cells through inactivation of the p-JAK2/p-STAT3 pathway. ---